Confo Therapeutics – Stabilize. Target. Discover. Transform.
Time 2022-09-08 15:02:25Web Name: Confo Therapeutics – Stabilize. Target. Discover. Transform.
WebSite: http://www.confotherapeutics.com
ID:308239
Keywords:
Therapeutics,Confo,Stabilize,TransformDescription:
CONFO THERAPEUTICS
Stabilize. Target. Discover. Transform.
Confo Therapeutics’ unparalleled technology stabilizes functional conformations of GPCRs (G protein-coupled receptors) to uncover a wide range of previously inaccessible drug targets.
Confo has attracted an international team of accomplished scientists and business professionals to deploy its innovative drug discovery platform on high value GPCR targets. With these valuable resources in place, Confo’s mission is to build a pipeline of drug candidates with the potential to transform therapeutic outcomes for patients with severe illnesses lacking disease-modifying treatments.
MORE ABOUT US“At Confo, our multi-faceted approach to building value starts from our outstanding technology, our stellar team and a growing proprietary pipeline of novel drug candidates. We further validate our approach through strategic partnerships with industry leaders and a strong consortium of global investors.”
CEDRIC VERVERKEN / CEO
INVESTORS
READ MOREOUR LATEST NEWS
Confo Therapeutics Awarded EUR 1.7M VLAIO Grant to Expand Application of ConfoBody® Drug Discovery and Development Technology in Rare Diseases
Ghent, Belgium – June 28, 2022 – Confo Therapeutics announced today that it has been awarded a EUR 1.7 million grant from Flanders Innovation & Entrepreneurship (VLAIO). The award further validates and supports Confo’s leadership in the discovery of novel GPCR (G protein-coupled receptor) drug candidates using its proprietary universal ConfoBody® technology, specifically for theJun 28, 2022
0
Confo Therapeutics Doses First Subjects in Phase 1 Clinical Trial of CFTX-1554 for the Treatment of Neuropathic Pain
— Confo’s first drug candidate moves into clinical development — Ghent, Belgium – March 10, 2022 – Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), today announced that the first subjects have been dosed in the company’s Phase 1, first-in-human trial of their clinical candidate CFTX-1554, a novel inhibitorMar 10, 2022
0
Confo Therapeutics Expands Patent Estate for ConfoBody®-based GPCR Screening Platform
Ghent, Belgium, December 15, 2021 – Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), today announced that it has extended its patent estate with four key US and EU patents granted as part of the company’s foundational “Steyaert patents”. The newly added patents (US-11,162,953, US-11,162,954, EP 3557254 and EPDec 15, 2021
0
HEADQUARTERS
Confo Therapeutics GhentHeadquarters & Drug Discovery labsTechnologiepark-Zwijnaarde 309052 GhentBelgiumTECHNOLOGY LABS
Confo Therapeutics BrusselsTechnology Development labsPleinlaan 2Building E, 7th Floor, Room E7.61050 Brussels, BelgiumINFO
Privacy Policy© Confo Therapeutics 2021 │ ConfoBody®, ConfoSensor® en ConfoScreen® are registered trademarks of Confo Therapeutics. MegaBody™ is a VIB trademark.
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Close
TAGS:Therapeutics Confo Stabilize Transform
<<< Thank you for your visit >>>
Websites to related : Smarthome, le confort de la mais
/*! elementor - v3.6.1 - 23-03-2022 */.elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image
Conforti Oleodinamica srl - ProdSelezione LINGUA ItalianoEnglishDeutschFrançais
Home - nobhilltherapeutics.comSkip to contentHomeTechnologyApplicationsTeamNewsContactHomeTechnologyApplicationsTeamNewsContactHomeTechnologyApplicationsContactNewsTeam×HomeT
PET-Transformatory[t] +48 61 892 88 98info@petransformatory.plWitamy PaństwaWitamy Państwa w Power Engineering Transformatory Sp. z o.o., w firmie z 65 letnią tradyc
GT | Simplifying Knowledge TransSolutions Publishing Education Manufacturing Business Company About GT Press Room Resources
Powerful, versatile protein engiamexus® - Ihr IT-Partner für d
Zeige Profil!
Manchmal bleibt einfach keine Zeit für eine klassische Bewerbung. Du möchtest dich aber trotzdem vorstellen? Dann überzeu
:root{--color_0:255,255,255;--color_1:0,0,0;--color_2:255,255,255;--color_3:237,28,36;--color_4:0,136,203;--color_5:255,203,5;--color_
Build Up | We transform conflictSkip to the content Home HomeAboutProgramsPeace InnovatorsDigital ConflictParticipatory ProcessesCommunity & LearningOpen Online CoursesWebina
Transformation Together - Homeads
Hot Websites